Helene Stenhoff

AstraZeneca (Sweden)

Papers

1

Total Citations

16

H-Index

1

About

Helene Stenhoff has made significant contributions to bioanalytical chemistry, with a primary focus on advancing automated sample preparation techniques for pharmaceutical analysis. Her most cited work, "Factorial design for the development of automated solid-phase extraction in the 96-well format for determination of tesaglitazar, in plasma, by liquid chromatography–mass spectrometry" (2003), exemplifies her expertise in optimizing high-throughput methodologies. This research, which has garnered 16 citations, demonstrates her skill in applying factorial design to streamline solid-phase extraction processes, enabling efficient and reliable quantification of drug compounds in biological matrices. Stenhoff’s work is particularly notable for its practical impact on drug development and pharmacokinetic studies, where rapid and accurate analysis is critical. By integrating automation with advanced mass spectrometry detection, she has helped reduce analysis time and improve reproducibility in pharmaceutical laboratories. Her achievements reflect a dedicated career in analytical method development, bridging the gap between theoretical design and real-world application. For students and researchers in bioanalysis, Stenhoff’s contributions offer a valuable model of how systematic optimization can enhance the efficiency and robustness of quantitative assays.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Factorial design for the development of automated solid-phase extraction in the 96-well format for determination of tesaglitazar, in plasma, by liquid chromatography–mass spectrometry
16 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: AstraZeneca (Sweden)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago